Open AccessPrevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
Author(s) -
David R. Martinez,
Alexandra Schäfer,
Sarah R. Leist,
Dapeng Li,
Kendra L. Gully,
Boyd L. Yount,
Joy Y. Feng,
Elaine Bunyan,
Danielle Porter,
Tomáš Cihlář,
Stephanie A. Montgomery,
Barton F. Haynes,
Ralph S. Baric,
Michel C. Nussenzweig,
Timothy P. Sheahan
Publication year - 2021
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.109450
Subject(s) - monoclonal antibody , medicine , antibody , in vivo , clinical trial , covid-19 , disease , virology , combination therapy , immunology , clinical efficacy , pharmacology , infectious disease (medical specialty) , biology , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom